• / Free eNewsletters & Magazine
  • / My Account
Home>European Commission

European Commission

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. France's Macron Will Work With Germany on EU Issues -- Update

    France's Macron Will Work With Germany on EU Issues -- Update

  2. Erythropoietin (EPO) Drugs Market Forecast to 2025 - Analysis By Drug Class (Biologics, Biosimilars), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), Application & Segment - Research ...

    Erythropoietin (EPO) Drugs Market Forecast to 2025 - Analysis By Drug Class (Biologics, Biosimilars), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), Application & Segment - Research and Markets

  3. EU Leaders Reach Political Deal to Extend Sanctions on Russia

    EU Leaders Reach Political Deal to Extend Sanctions on Russia

  4. News Highlights: Top Financial Services News of the Day

    News Highlights: Top Financial Services News of the Day

  5. News Highlights: Top Financial Services News of the Day

    News Highlights: Top Financial Services News of the Day

  6. News Highlights: Top Financial Services News of the Day

    News Highlights: Top Financial Services News of the Day

  7. News Highlights: Top Financial Services News of the Day

    News Highlights: Top Financial Services News of the Day

  8. Ipsen and its partner Exelixis announce independent radiology committee review confirms results from Phase 2 CABOSUN trial of cabozantinib versus sunitinib in previously untreated advanced renal cell ...

    Ipsen and its partner Exelixis announce independent radiology committee review confirms results from Phase 2 CABOSUN trial of cabozantinib versus sunitinib in previously untreated advanced renal cell carcinoma

  9. Google Faces EU Antitrust Fine -- WSJ

    Google Faces EU Antitrust Fine -- WSJ

  10. TxCell Appoints Lentigen Technology, Inc. To Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection

    TxCell Appoints Lentigen Technology, Inc. To Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection

12345

©2017 Morningstar Advisor. All right reserved.